Researchers have long searched to understand why diseases like lupus and rheumatoid arthritis disproportionately affect women. Now, findings from the Oklahoma Medical Research Foundation shed some new light.
0%
Researchers have long searched to understand why diseases like lupus and rheumatoid arthritis disproportionately affect women. Now, findings from the Oklahoma Medical Research Foundation shed some new light.
At the crossroads of Interstate 35 and Highway 77 and just blocks away from both the State Capitol and downtown’s thriving Central Business District, Oklahoma City’s budding innovation district is helping diversify the city’s growing economy and bringing international notoriety.
An Oklahoma Medical Research Foundation scientist has discovered that certain sugars produced by the body play an important role in the development of colitis and, ultimately, colon cancer. The new finding could potentially lead to therapies for ulcerative colitis, Crohn’s disease and colon cancer.
Executive Q&A with Mike Centola, founder of Haus Bioceuticals
While it may sound simple, cell division requires precise timing to avoid catastrophic results, like cancer, where cells divide unchecked, or birth defects caused by an incorrect number of chromosomes
In October, the Brookings Institute announced Oklahoma City as one of two pilot cities that are part of a study into developing an Innovation District. It already has held informational meetings and tours to gather ideas on just what that might look like.
Going forward, these new findings could play a key role in tailoring treatments for individuals who suffer from or are at an increased risk for lupus, a disease in which the immune system becomes unbalanced and attacks the body’s own tissues. Lupus can result in damage to the joints, skin, kidneys, heart and lungs.
It’s a rare moment that the leaders and scientists of Oklahoma’s bioscience industry can come together to share the collaborative spirit that is such a part of who they are and what they are creating. The annual OKBIO Summit and BioScience Awards dinner is one of those moments.
OMRF scientist discovers new multiple sclerosis biomarkers By OMRF Copyright © 2016, OMRF In new research from OMRF, scientists have discovered subtle biological signs in the development of multiple sclerosis that point to the need for highly individualized treatment plans for patients suffering from the disease. MS damages the nervous system’s ability to carry signalsRead more
The National Institute of Dental and Craniofacial Research has awarded Oklahoma Medical Research Foundation scientist Umesh S. Deshmukh, Ph.D., a five-year, $2.14 million grant to investigate the biological origins and development of Sjögren’s syndrome.
